Astral Systems
Producing life-saving cancer isotopes through compact fusion technology.
Bristol, United Kingdom · Founded 2021 · $30.0M raised
- Headquarters
- Bristol
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- astralsystems.co.uk
- Total Funding
- $30.0M
- Last Round
- $30.0M Series AJun 2026
- Rounds
- 1
About
Astral Systems is a Bristol-based deep tech company developing Multi-State Fusion (MSF) reactor technology to produce medical isotopes for cancer diagnosis and treatment. Its compact fusion reactors generate high-intensity neutron beams that irradiate target materials to create radioisotopes including Actinium-225 and Lead-212 — isotopes in critical short supply globally. Astral's reactors operate at Technology Readiness Level 9, with the company having generated over £3M in research contract revenue. Founded in 2021 by Talmon Firestone and Dr. Tom Wallace-Smith, the company builds on NASA's discovery of lattice confinement fusion and a decade of NSD fusion commercialization. It raised a £23M Series A in 2026 to scale production.
Summary
Astral Systems is a Deep Tech company based in Bristol, United Kingdom, founded in 2021. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Jun 2026. Investors include Mercia Fund Management.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2026
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe